A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy
NCT04254172 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2
Last updated 2021-10-15
Summary
The purpose of this low interventional study is to collect data on everyday movement in boys with Duchenne muscular dystrophy (DMD) using wearable activity sensors. The activity sensors could provide useful information beyond what is currently collected by functional (movement, strength) assessments in clinic. This information can help with the understanding of the impact of DMD, and perhaps with how possible treatments can affect this impact.
Conditions
- Duchenne Muscular Dystrophy (DMD)
Interventions
- DEVICE
-
Activity Monitor
Wrist and ankle sensors to be worn continuously for 2-week intervals.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 4 Years
- Max Age
- 12 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-19
- Primary Completion
- 2020-08-19
- Completion
- 2020-08-19
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
NCT02760264 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
NCT01462292 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy
NCT05281120 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
NCT02420379 ·Status: COMPLETED ·Phase: PHASE2
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy
NCT05429372 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 ·Status: COMPLETED
-
This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy
NCT01098708 ·Status: COMPLETED
-
Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
NCT03319030 ·Status: COMPLETED
-
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
NCT03038399 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
NCT02195999 ·Status: COMPLETED
-
An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy
NCT06270719 ·Status: ENROLLING_BY_INVITATION
-
Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy
NCT01954940 ·Status: COMPLETED ·Phase: NA
-
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD
NCT02515669 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Burden of Access in Duchenne Muscular Dystrophy in the US
NCT03951675 ·Status: COMPLETED
-
Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy
NCT04529707 ·Status: COMPLETED ·Phase: NA
-
An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
NCT02760277 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
NCT01753804 ·Status: TERMINATED
-
A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)
NCT00018109 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
NCT02851797 ·Status: COMPLETED ·Phase: PHASE3
-
Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy
NCT01451281 ·Status: COMPLETED
-
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
NCT03400852 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
NCT01225614 ·Status: UNKNOWN ·Phase: PHASE3
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA